About
Ad Scientiam is a healthcare technology company founded in 2013, focused on developing mobile health solutions and real-world medical data analysis to enhance patient care and expedite drug development. Based at the Brain & Spine Institute of la Pitié-Salpêtrière Hospital in Paris, the company creates clinically validated software applications that help patients with chronic diseases monitor their health outside of clinical settings. The flagship product, MSCopilot, is a CE-marked software application for monitoring Multiple Sclerosis. It allows patients to conduct regular digital tests at home to track disease progression. Ad Scientiam is also developing a pipeline of additional solutions for chronic conditions such as rheumatoid arthritis, depression, and Parkinson’s disease, along with digital biomarkers that provide actionable insights for patients and healthcare professionals. The company collaborates with pharmaceutical firms to enhance drug development processes and aims to expand its presence in the United States, focusing on digital health solutions for chronic disease management.
Technologies
Keywords
Company Information
-
Employees 45
-
Founded 2013
-
Annual Revenue $414000
-
Total Funding $2309538
Location
21 Rue Albert Bayet, Paris, Ile-de-France, France, 75013
